NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹5,789 Cr | ₹3,311 Cr | ₹2,863 Cr | ₹2,657 Cr | ₹2,622 Cr |
What is the latest Total Non-Current Assets ratio of NATCO PHARMA ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2026 | ₹5,789 Cr |
| Mar2025 | ₹3,311 Cr |
| Mar2024 | ₹2,863 Cr |
| Mar2023 | ₹2,657 Cr |
| Mar2022 | ₹2,622 Cr |
How is Total Non-Current Assets of NATCO PHARMA Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹5,789 Cr | 74.85 | |
| Mar2025 | ₹3,311 Cr | 15.62 | |
| Mar2024 | ₹2,863 Cr | 7.76 | |
| Mar2023 | ₹2,657 Cr | 1.32 | |
| Mar2022 | ₹2,622 Cr | - | |
Compare Total Non-Current Assets of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹14,798.1 Cr | -2% | -9.4% | -3.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,316.0 Cr | -2.7% | -3.7% | 20.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,737.0 Cr | 3.7% | 15.7% | 51% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,594.0 Cr | -0.8% | 1% | 36.2% | Stock Analytics | |
| CIPLA | ₹110,515.0 Cr | -2.1% | -5.2% | -11.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,420.6 Cr | -0.8% | -0.5% | -9.3% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -2% |
-9.4% |
-3.9% |
| SENSEX | -2.4% |
-4.8% |
-7.2% |
You may also like the below Video Courses